Cover Image
Market Research Report
Product code 
936473

Global Submental Fat Treatment Market - Industry Trends and Forecast to 2027

Published: | Data Bridge Market Research Private Limited | 203 Pages | Delivery time: Inquiry

Price

Back to Top
Global Submental Fat Treatment Market - Industry Trends and Forecast to 2027
Published: April 1, 2020
Data Bridge Market Research Private Limited
Content info: 203 Pages
Delivery time: Inquiry
  • Description
  • Table of Contents
  • List of Tables

Global submental fat treatment market is projected to register a substantial CAGR of 13.2% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027

Market Segmentation

Global Submental Fat Treatment Market By Type (Invasive Method, Minimally Invasive & Non Invasive Technology), End User (Cosmetic Centers, Hospitals, Dermatology Clinics, Medical Spa, Others), Distribution Channel (Direct Tender, Retail Sales), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, Brazil, Argentina and Rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and Rest of Middle East and Africa) Industry Trends & Forecast to 2027.

Some of the major factors contributing to the growth of the global submental fat treatment market are:

Rising prevalence of obesity

Increased reliability on liposuction procedure

Market Players

The key market players for global submental fat treatment market are listed below:

Allergan plc

CANDELA CORPORATION

Cynosure LLC

Lumenis

INMODE

Cutera

Laser Lipo Ltd

Solta Medical

ERCHONIA CORPORATION

ThermiGen, LLC.

BTL Group of Companies

Alma Lasers (A Subsidiary of Sisram Medical Ltd)

HIRONIC CO., LTD.

ENDYMED MEDICAL

TABLE OF CONTENTS

1 INTRODUCTION 22

  • 1.1 OBJECTIVES OF THE STUDY 22
  • 1.2 MARKET DEFINITION 22
  • 1.3 OVERVIEW OF GLOBAL SUBMENTAL FAT TREATMENT MARKET 23
  • 1.4 CURRENCY AND PRICING 24
  • 1.5 LIMITATIONS 24
  • 1.6 MARKETS COVERED 24

2 MARKET SEGMENTATION 27

  • 2.1 MARKETS COVERED 27
  • 2.2 GEOGRAPHICAL SCOPE 28
  • 2.3 YEARS CONSIDERED FOR THE STUDY 29
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 30
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 33
  • 2.6 MULTIVARIATE MODELLING 34
  • 2.7 TYPE LIFELINE CURVE 34
  • 2.8 DBMR MARKET POSITION GRID 35
  • 2.9 MARKET APPLICATION COVERAGE GRID 37
  • 2.10 VENDOR SHARE ANALYSIS 37
  • 2.11 SECONDARY SOURCES 38
  • 2.12 ASSUMPTIONS 38

3 EXECUTIVE SUMMARY 39

4 INDUSTRY INSIGHTS 44

  • 4.1 REIMBURSEMENT SCENARIO 44

5 MARKET OVERVIEW 45

  • 5.1 DRIVERS 47
    • 5.1.1 INCREASING AWARENESS FOR COSMETIC PROCEDURES AMONG PEOPLE 47
    • 5.1.2 RISING PREVALENCE OF OBESITY 47
    • 5.1.3 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 48
    • 5.1.4 INCREASED RELIABILITY ON LIPOSUCTION PROCEDURE 49
    • 5.1.5 AVAILABILITY OF ADVANCED AND USER FRIENDLY PRODUCTS 49
  • 5.2 RESTRAINTS 50
    • 5.2.1 HIGH COST OF PROCEDURES 50
    • 5.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES 50
    • 5.2.3 STRINGENT REGULATIONS FOR APPROVAL OF PRODUCTS 51

  • 5.3 OPPORTUNITIES 52
    • 5.3.1 EVOLUTION IN LASER AND RF DEVICES 52
    • 5.3.2 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR COSMETIC PROCEDURES 53
    • 5.3.3 INTRODUCTION OF NOVEL NON- INVASIVE TECHNOLOGY 53
  • 5.4 CHALLENGES 54
    • 5.4.1 INCREASED RECOVERY TIME OF PROCEDURES 54
    • 5.4.2 REQUIREMENT OF MULTIPLE SESSIONS FOR GETTING MAXIMUM RESULTS 54

6 GLOBAL SUBMENTAL FAT TREATMENT MARKET, BY TYPE 55

  • 6.1 OVERVIEW 56
  • 6.2 MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY 59
    • 6.2.1 ULTRASOUND 59
    • 6.2.2 CRYOLIPOLYSIS 60
    • 6.2.3 RADIOFREQUENCY-ASSISTED CONTOURING 60
    • 6.2.4 LOW-LEVEL LASERS 60
    • 6.2.5 COMBINATION TREATMENT 60
    • 6.2.6 INJECTABLE ADIPOCYTOLYSIS 60
    • 6.2.7 OTHERS 60
  • 6.3 INVASIVE METHOD 61
    • 6.3.1 LIPOSUCTION 61
    • 6.3.2 SURGICAL REJUVENATION 61
    • 6.3.3 CHIN IMPLANT 61

7 GLOBAL SUBMENTAL FAT TREATMENT MARKET, BY END USER 62

  • 7.1 OVERVIEW 63
  • 7.2 COSMETIC CENTERS 66
  • 7.3 HOSPITALS 66
  • 7.4 DERMATOLOGY CLINICS 67
  • 7.5 MEDICAL SPA 67
  • 7.6 OTHERS 68

8 GLOBAL SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL 69

  • 8.1 OVERVIEW 70
  • 8.2 DIRECT TENDER 73
  • 8.3 RETAIL SALES 73

9 GLOBAL SUBMENTAL FAT TREATMENT MARKET, BY GEOGRAPHY 74

  • 9.1 OVERVIEW 75
  • 9.2 NORTH AMERICA 80
    • 9.2.1 U.S. 85
    • 9.2.2 CANADA 87
    • 9.2.3 MEXICO 89
  • 9.3 EUROPE 91
    • 9.3.1 GERMANY 96
    • 9.3.2 FRANCE 98
    • 9.3.3 ITALY 100
    • 9.3.4 U.K. 102
    • 9.3.5 SPAIN 104
    • 9.3.6 RUSSIA 106
    • 9.3.7 NETHERLANDS 108
    • 9.3.8 SWITZERLAND 110
    • 9.3.9 BELGIUM 112
    • 9.3.10 TURKEY 114
    • 9.3.11 REST OF EUROPE 116
  • 9.4 ASIA-PACIFIC 117
    • 9.4.1 JAPAN 122
    • 9.4.2 CHINA 124
    • 9.4.3 AUSTRALIA 126
    • 9.4.4 SOUTH KOREA 128
    • 9.4.5 SINGAPORE 130
    • 9.4.6 INDIA 132
    • 9.4.7 MALAYSIA 134
    • 9.4.8 THAILAND 136
    • 9.4.9 INDONESIA 138
    • 9.4.10 PHILIPPINES 140
    • 9.4.11 REST OF ASIA-PACIFIC 142
  • 9.5 SOUTH AMERICA 143
    • 9.5.1 BRAZIL 148
    • 9.5.2 ARGENTINA 150
    • 9.5.3 REST OF SOUTH AMERICA 152
  • 9.6 MIDDLE EAST & AFRICA 153
    • 9.6.1 SAUDI ARABIA 158
    • 9.6.2 SOUTH AFRICA 160
    • 9.6.3 U.A.E. 162
    • 9.6.4 ISRAEL 164
    • 9.6.5 EGYPT 166
    • 9.6.6 REST OF MIDDLE EAST & AFRICA 168

10 GLOBAL SUBMENTAL FAT TREATMENT MARKET, COMPANY LANDSCAPE 169

  • 10.1 COMPANY SHARE ANALYSIS: GLOBAL 169
  • 10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 170
  • 10.3 COMPANY SHARE ANALYSIS: EUROPE 171
  • 10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 172

11 SWOT & DATA BRIDGE MARKET RESEARCH ANALYSIS 173

  • 11.1 SWOT ANALYSIS 173
    • 11.1.1 STRENGTH: - SIGNIFICANT GROWTH OF SHARES IN MARKET FOCUSED SEGMENT 173
    • 11.1.2 STRENGTH: - FOCUSED ON AESTHETIC SOLUTIONS 173
    • 11.1.3 WEAKNESS: DEPENDENCE ON SUPPLIERS/ DISTRIBUTORS 174
    • 11.1.4 OPPORTUNITY: - STRATEGIC INITIATIVES FOR BUSINESS EXPANISION BY PRODUCT LAUNCH, ACQUISITION AND OTHERS 174
    • 11.1.5 THREAT: - CURRENCY FLUCTUATION 175
  • 11.2 DATA BRIDGE MARKET RESEARCH ANALYSIS 175

12 COMPANY PROFILE 176

  • 12.1 ALLERGAN 176
    • 12.1.1 COMPANY SNAPSHOT 176
    • 12.1.2 REVENUE ANALYSIS 177
    • 12.1.3 COMPANY SHARE ANALYSIS 177
    • 12.1.4 PRODUCT PORTFOLIO 178
    • 12.1.5 RECENT DEVELOPMENTS 178
  • 12.2 INMODE 179
    • 12.2.1 COMPANY SNAPSHOT 179
    • 12.2.2 REVENUE ANALYSIS 180
    • 12.2.3 COMPANY SHARE ANALYSIS 180
    • 12.2.4 PRODUCT PORTFOLIO 181
    • 12.2.5 RECENT DEVELOPMENT 181
  • 12.3 HIRONIC CO., LTD. 182
    • 12.3.1 COMPANY SNAPSHOT 182
    • 12.3.2 REVENUE ANALYSIS 182
    • 12.3.3 COMPANY SHARE ANALYSIS 183
    • 12.3.4 PRODUCT PORTFOLIO 183
    • 12.3.5 RECENT DEVELOPMENT 183
  • 12.4 CANDELA CORPORATION 184
    • 12.4.1 COMPANY SNAPSHOT 184
    • 12.4.2 COMPANY SHARE ANALYSIS 184
    • 12.4.3 PRODUCT PORTFOLIO 185
    • 12.4.4 RECENT DEVELOPMENT 185
  • 12.5 CYNOSURE LLC 186
    • 12.5.1 COMPANY SNAPSHOT 186
    • 12.5.2 PRODUCT PORTFOLIO 186
    • 12.5.3 RECENT DEVELOPMENTS 186

  • 12.6 BTL GROUP OF COMPANIES 187
    • 12.6.1 COMPANY SNAPSHOT 187
    • 12.6.2 SOLUTION PORTFOLIO 187
    • 12.6.3 RECENT DEVELOPMENTS 187
  • 12.7 ALMA LASERS (A SUBSIDIARY OF SISRAM MEDICAL LTD) 188
    • 12.7.1 COMPANY SNAPSHOT 188
    • 12.7.2 REVENUE ANALYSIS 188
    • 12.7.3 PRODUCT PORTFOLIO 189
    • 12.7.4 RECENT DEVELOPMENTS 189
  • 12.8 ENDYMED MEDICAL 190
    • 12.8.1 COMPANY SNAPSHOT 190
    • 12.8.2 REVENUE ANALYSIS 190
    • 12.8.3 PRODUCT PORTFOLIO 191
    • 12.8.4 RECENT DEVELOPMENT 191
  • 12.9 CUTERA 192
    • 12.9.1 COMPANY SNAPSHOT 192
    • 12.9.2 REVENUE ANALYSIS 193
    • 12.9.3 PRODUCT PORTFOLIO 193
    • 12.9.4 RECENT DEVELOPMENT 193
  • 12.10 ALASTIN SKINCARE, INC. 194
    • 12.10.1 COMPANY SNAPSHOT 194
    • 12.10.2 PRODUCT PORTFOLIO 194
    • 12.10.3 RECENT DEVELOPMENTS 194
  • 12.11 ERCHONIA CORPORATION 195
    • 12.11.1 COMPANY SNAPSHOT 195
    • 12.11.2 PRODUCT PORTFOLIO 195
    • 12.11.3 RECENT DEVELOPMENT 195
  • 12.12 LASER LIPO LTD. 196
    • 12.12.1 COMPANY SNAPSHOT 196
    • 12.12.2 PRODUCT PORTFOLIO 196
    • 12.12.3 RECENT DEVELOPMENT 196
  • 12.13 LUMENIS 197
    • 12.13.1 COMPANY SNAPSHOT 197
    • 12.13.2 PRODUCT PORTFOLIO 197
    • 12.13.3 RECENT DEVELOPMENT 197
  • 12.14 SOLTA MEDICAL 198
    • 12.14.1 COMPANY SNAPSHOT 198
    • 12.14.2 BRAND PORTFOLIO 198
    • 12.14.3 RECENT DEVELOPMENT 198

  • 12.15 THERMIGEN, LLC. 199
    • 12.15.1 COMPANY SNAPSHOT 199
    • 12.15.2 PRODUCT PORTFOLIO 199
    • 12.15.3 RECENT DEVELOPMENT 199

13 QUESTIONNAIRE 200

14 CONCLUSION 202

15 RELATED REPORTS 203

LIST OF TABLES

1 INTRODUCTION 22

  • 1.1 OBJECTIVES OF THE STUDY 22
  • 1.2 MARKET DEFINITION 22
  • 1.3 OVERVIEW OF GLOBAL SUBMENTAL FAT TREATMENT MARKET 23
  • 1.4 CURRENCY AND PRICING 24
  • 1.5 LIMITATIONS 24
  • 1.6 MARKETS COVERED 24

2 MARKET SEGMENTATION 27

  • 2.1 MARKETS COVERED 27
  • 2.2 GEOGRAPHICAL SCOPE 28
  • 2.3 YEARS CONSIDERED FOR THE STUDY 29
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 30
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 33
  • 2.6 MULTIVARIATE MODELLING 34
  • 2.7 TYPE LIFELINE CURVE 34
  • 2.8 DBMR MARKET POSITION GRID 35
  • 2.9 MARKET APPLICATION COVERAGE GRID 37
  • 2.10 VENDOR SHARE ANALYSIS 37
  • 2.11 SECONDARY SOURCES 38
  • 2.12 ASSUMPTIONS 38

3 EXECUTIVE SUMMARY 39

4 INDUSTRY INSIGHTS 44

  • 4.1 REIMBURSEMENT SCENARIO 44

5 MARKET OVERVIEW 45

  • 5.1 DRIVERS 47
    • 5.1.1 INCREASING AWARENESS FOR COSMETIC PROCEDURES AMONG PEOPLE 47
    • 5.1.2 RISING PREVALENCE OF OBESITY 47
    • 5.1.3 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 48
    • 5.1.4 INCREASED RELIABILITY ON LIPOSUCTION PROCEDURE 49
    • 5.1.5 AVAILABILITY OF ADVANCED AND USER FRIENDLY PRODUCTS 49
  • 5.2 RESTRAINTS 50
    • 5.2.1 HIGH COST OF PROCEDURES 50
    • 5.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES 50
    • 5.2.3 STRINGENT REGULATIONS FOR APPROVAL OF PRODUCTS 51

  • 5.3 OPPORTUNITIES 52
    • 5.3.1 EVOLUTION IN LASER AND RF DEVICES 52
    • 5.3.2 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR COSMETIC PROCEDURES 53
    • 5.3.3 INTRODUCTION OF NOVEL NON- INVASIVE TECHNOLOGY 53
  • 5.4 CHALLENGES 54
    • 5.4.1 INCREASED RECOVERY TIME OF PROCEDURES 54
    • 5.4.2 REQUIREMENT OF MULTIPLE SESSIONS FOR GETTING MAXIMUM RESULTS 54

6 GLOBAL SUBMENTAL FAT TREATMENT MARKET, BY TYPE 55

  • 6.1 OVERVIEW 56
  • 6.2 MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY 59
    • 6.2.1 ULTRASOUND 59
    • 6.2.2 CRYOLIPOLYSIS 60
    • 6.2.3 RADIOFREQUENCY-ASSISTED CONTOURING 60
    • 6.2.4 LOW-LEVEL LASERS 60
    • 6.2.5 COMBINATION TREATMENT 60
    • 6.2.6 INJECTABLE ADIPOCYTOLYSIS 60
    • 6.2.7 OTHERS 60
  • 6.3 INVASIVE METHOD 61
    • 6.3.1 LIPOSUCTION 61
    • 6.3.2 SURGICAL REJUVENATION 61
    • 6.3.3 CHIN IMPLANT 61

7 GLOBAL SUBMENTAL FAT TREATMENT MARKET, BY END USER 62

  • 7.1 OVERVIEW 63
  • 7.2 COSMETIC CENTERS 66
  • 7.3 HOSPITALS 66
  • 7.4 DERMATOLOGY CLINICS 67
  • 7.5 MEDICAL SPA 67
  • 7.6 OTHERS 68

8 GLOBAL SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL 69

  • 8.1 OVERVIEW 70
  • 8.2 DIRECT TENDER 73
  • 8.3 RETAIL SALES 73

9 GLOBAL SUBMENTAL FAT TREATMENT MARKET, BY GEOGRAPHY 74

  • 9.1 OVERVIEW 75
  • 9.2 NORTH AMERICA 80
    • 9.2.1 U.S. 85
    • 9.2.2 CANADA 87
    • 9.2.3 MEXICO 89
  • 9.3 EUROPE 91
    • 9.3.1 GERMANY 96
    • 9.3.2 FRANCE 98
    • 9.3.3 ITALY 100
    • 9.3.4 U.K. 102
    • 9.3.5 SPAIN 104
    • 9.3.6 RUSSIA 106
    • 9.3.7 NETHERLANDS 108
    • 9.3.8 SWITZERLAND 110
    • 9.3.9 BELGIUM 112
    • 9.3.10 TURKEY 114
    • 9.3.11 REST OF EUROPE 116
  • 9.4 ASIA-PACIFIC 117
    • 9.4.1 JAPAN 122
    • 9.4.2 CHINA 124
    • 9.4.3 AUSTRALIA 126
    • 9.4.4 SOUTH KOREA 128
    • 9.4.5 SINGAPORE 130
    • 9.4.6 INDIA 132
    • 9.4.7 MALAYSIA 134
    • 9.4.8 THAILAND 136
    • 9.4.9 INDONESIA 138
    • 9.4.10 PHILIPPINES 140
    • 9.4.11 REST OF ASIA-PACIFIC 142
  • 9.5 SOUTH AMERICA 143
    • 9.5.1 BRAZIL 148
    • 9.5.2 ARGENTINA 150
    • 9.5.3 REST OF SOUTH AMERICA 152
  • 9.6 MIDDLE EAST & AFRICA 153
    • 9.6.1 SAUDI ARABIA 158
    • 9.6.2 SOUTH AFRICA 160
    • 9.6.3 U.A.E. 162
    • 9.6.4 ISRAEL 164
    • 9.6.5 EGYPT 166
    • 9.6.6 REST OF MIDDLE EAST & AFRICA 168

10 GLOBAL SUBMENTAL FAT TREATMENT MARKET, COMPANY LANDSCAPE 169

  • 10.1 COMPANY SHARE ANALYSIS: GLOBAL 169
  • 10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 170
  • 10.3 COMPANY SHARE ANALYSIS: EUROPE 171
  • 10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 172

11 SWOT & DATA BRIDGE MARKET RESEARCH ANALYSIS 173

  • 11.1 SWOT ANALYSIS 173
    • 11.1.1 STRENGTH: - SIGNIFICANT GROWTH OF SHARES IN MARKET FOCUSED SEGMENT 173
    • 11.1.2 STRENGTH: - FOCUSED ON AESTHETIC SOLUTIONS 173
    • 11.1.3 WEAKNESS: DEPENDENCE ON SUPPLIERS/ DISTRIBUTORS 174
    • 11.1.4 OPPORTUNITY: - STRATEGIC INITIATIVES FOR BUSINESS EXPANISION BY PRODUCT LAUNCH, ACQUISITION AND OTHERS 174
    • 11.1.5 THREAT: - CURRENCY FLUCTUATION 175
  • 11.2 DATA BRIDGE MARKET RESEARCH ANALYSIS 175

12 COMPANY PROFILE 176

  • 12.1 ALLERGAN 176
    • 12.1.1 COMPANY SNAPSHOT 176
    • 12.1.2 REVENUE ANALYSIS 177
    • 12.1.3 COMPANY SHARE ANALYSIS 177
    • 12.1.4 PRODUCT PORTFOLIO 178
    • 12.1.5 RECENT DEVELOPMENTS 178
  • 12.2 INMODE 179
    • 12.2.1 COMPANY SNAPSHOT 179
    • 12.2.2 REVENUE ANALYSIS 180
    • 12.2.3 COMPANY SHARE ANALYSIS 180
    • 12.2.4 PRODUCT PORTFOLIO 181
    • 12.2.5 RECENT DEVELOPMENT 181
  • 12.3 HIRONIC CO., LTD. 182
    • 12.3.1 COMPANY SNAPSHOT 182
    • 12.3.2 REVENUE ANALYSIS 182
    • 12.3.3 COMPANY SHARE ANALYSIS 183
    • 12.3.4 PRODUCT PORTFOLIO 183
    • 12.3.5 RECENT DEVELOPMENT 183
  • 12.4 CANDELA CORPORATION 184
    • 12.4.1 COMPANY SNAPSHOT 184
    • 12.4.2 COMPANY SHARE ANALYSIS 184
    • 12.4.3 PRODUCT PORTFOLIO 185
    • 12.4.4 RECENT DEVELOPMENT 185
  • 12.5 CYNOSURE LLC 186
    • 12.5.1 COMPANY SNAPSHOT 186
    • 12.5.2 PRODUCT PORTFOLIO 186
    • 12.5.3 RECENT DEVELOPMENTS 186

  • 12.6 BTL GROUP OF COMPANIES 187
    • 12.6.1 COMPANY SNAPSHOT 187
    • 12.6.2 SOLUTION PORTFOLIO 187
    • 12.6.3 RECENT DEVELOPMENTS 187
  • 12.7 ALMA LASERS (A SUBSIDIARY OF SISRAM MEDICAL LTD) 188
    • 12.7.1 COMPANY SNAPSHOT 188
    • 12.7.2 REVENUE ANALYSIS 188
    • 12.7.3 PRODUCT PORTFOLIO 189
    • 12.7.4 RECENT DEVELOPMENTS 189
  • 12.8 ENDYMED MEDICAL 190
    • 12.8.1 COMPANY SNAPSHOT 190
    • 12.8.2 REVENUE ANALYSIS 190
    • 12.8.3 PRODUCT PORTFOLIO 191
    • 12.8.4 RECENT DEVELOPMENT 191
  • 12.9 CUTERA 192
    • 12.9.1 COMPANY SNAPSHOT 192
    • 12.9.2 REVENUE ANALYSIS 193
    • 12.9.3 PRODUCT PORTFOLIO 193
    • 12.9.4 RECENT DEVELOPMENT 193
  • 12.10 ALASTIN SKINCARE, INC. 194
    • 12.10.1 COMPANY SNAPSHOT 194
    • 12.10.2 PRODUCT PORTFOLIO 194
    • 12.10.3 RECENT DEVELOPMENTS 194
  • 12.11 ERCHONIA CORPORATION 195
    • 12.11.1 COMPANY SNAPSHOT 195
    • 12.11.2 PRODUCT PORTFOLIO 195
    • 12.11.3 RECENT DEVELOPMENT 195
  • 12.12 LASER LIPO LTD. 196
    • 12.12.1 COMPANY SNAPSHOT 196
    • 12.12.2 PRODUCT PORTFOLIO 196
    • 12.12.3 RECENT DEVELOPMENT 196
  • 12.13 LUMENIS 197
    • 12.13.1 COMPANY SNAPSHOT 197
    • 12.13.2 PRODUCT PORTFOLIO 197
    • 12.13.3 RECENT DEVELOPMENT 197
  • 12.14 SOLTA MEDICAL 198
    • 12.14.1 COMPANY SNAPSHOT 198
    • 12.14.2 BRAND PORTFOLIO 198
    • 12.14.3 RECENT DEVELOPMENT 198

  • 12.15 THERMIGEN, LLC. 199
    • 12.15.1 COMPANY SNAPSHOT 199
    • 12.15.2 PRODUCT PORTFOLIO 199
    • 12.15.3 RECENT DEVELOPMENT 199

13 QUESTIONNAIRE 200

14 CONCLUSION 202

15 RELATED REPORTS 203

LIST OF FIGURES

  • FIGURE 1 GLOBAL SUBMENTAL FAT TREATMENT MARKET: SEGMENTATION 27
  • FIGURE 2 GLOBAL SUBMENTAL FAT TREATMENT MARKET: DATA TRIANGULATION 30
  • FIGURE 3 GLOBAL SUBMENTAL FAT TREATMENT MARKET: DROC ANALYSIS 31
  • FIGURE 4 GLOBAL SUBMENTAL FAT TREATMENT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 32
  • FIGURE 5 GLOBAL SUBMENTAL FAT TREATMENT MARKET: COMPANY RESEARCH ANALYSIS 32
  • FIGURE 6 GLOBAL SUBMENTAL FAT TREATMENT MARKET: INTERVIEW DEMOGRAPHICS 33
  • FIGURE 7 GLOBAL SUBMENTAL FAT TREATMENTMARKET: DBMR MARKET POSITION GRID 35
  • FIGURE 8 GLOBAL SUBMENTAL FAT TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID 37
  • FIGURE 9 GLOBAL SUBMENTAL FAT TREATMENT MARKET: VENDOR SHARE ANALYSIS 37
  • FIGURE 10 GLOBAL SUBMENTAL FAT TREATMENT MARKET: SEGMENTATION 40
  • FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL SUBMENTAL FAT TREATMENT MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027 41
  • FIGURE 12 GROWING FOCUS ON AESTHETICS AND EXPANSION OF TARGET DEMOGRAPHICS ARE EXPECTED TO DRIVE THE GLOBAL SUBMENTAL FAT TREATMENT MARKET IN THE FORECAST PERIOD OF 2020 TO 2027 42
  • FIGURE 13 MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL SUBMENTAL FAT TREATMENT MARKET IN 2020 & 2027 42
  • FIGURE 14 ASIA-PACIFIC IS THE MAXIMUM GROWING REGION FOR SUBMENTAL FAT TREATMENT MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027 43
  • FIGURE 15 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF GLOBAL SUBMENTAL FAT TREATMENT MARKET 46
  • FIGURE 16 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY TYPE, 2019 56
  • FIGURE 17 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY TYPE, 2019-2027 (USD MILLION) 57
  • FIGURE 18 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY TYPE, CAGR (2020-2027) 57
  • FIGURE 19 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY TYPE, LIFELINE CURVE 58
  • FIGURE 20 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY END USER, 2019 63
  • FIGURE 21 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY END USER, 2019-2027 (USD MILLION) 64
  • FIGURE 22 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY END USER, CAGR (2020-2027) 64
  • FIGURE 23 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY END USER, LIFELINE CURVE 65
  • FIGURE 24 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019 70
  • FIGURE 25 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION) 71
  • FIGURE 26 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027) 71
  • FIGURE 27 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 72
  • FIGURE 28 GLOBAL SUBMENTAL FAT TREATMENT MARKET: SNAPSHOT (2019) 76
  • FIGURE 29 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019) 77
  • FIGURE 30 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2020 & 2027) 77
  • FIGURE 31 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019 & 2027) 78
  • FIGURE 32 GLOBAL SUBMENTAL FAT TREATMENT MARKET: BY TYPE (2020-2027) 78
  • FIGURE 33 NORTH AMERICA SUBMENTAL FAT TREATMENT MARKET: SNAPSHOT (2019) 80
  • FIGURE 34 NORTH AMERICA SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019) 81
  • FIGURE 35 NORTH AMERICA SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2020 & 2027) 81
  • FIGURE 36 NORTH AMERICA SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019 & 2027) 82
  • FIGURE 37 NORTH AMERICA SUBMENTAL FAT TREATMENT MARKET: BY TYPE (2020-2027) 82
  • FIGURE 38 EUROPE SUBMENTAL FAT TREATMENT MARKET: SNAPSHOT (2019) 91
  • FIGURE 39 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019) 92
  • FIGURE 40 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2020 & 2027) 92
  • FIGURE 41 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019 & 2027) 93
  • FIGURE 42 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY TYPE (2020-2027) 93
  • FIGURE 43 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: SNAPSHOT (2019) 117
  • FIGURE 44 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019) 118
  • FIGURE 45 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2020 & 2027) 118
  • FIGURE 46 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019 & 2027) 119
  • FIGURE 47 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: BY TYPE (2020-2027) 119
  • FIGURE 48 SOUTH AMERICA SUBMENTAL FAT TREATMENT MARKET: SNAPSHOT (2019) 143
  • FIGURE 49 SOUTH AMERICA SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019) 144
  • FIGURE 50 SOUTH AMERICA SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2020 & 2027) 144
  • FIGURE 51 SOUTH AMERICA SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019 & 2027) 145
  • FIGURE 52 SOUTH AMERICA SUBMENTAL FAT TREATMENT MARKET: BY TYPE (2020-2027) 145
  • FIGURE 53 MIDDLE EAST & AFRICA SUBMENTAL FAT TREATMENT MARKET: SNAPSHOT (2019) 153
  • FIGURE 54 MIDDLE EAST & AFRICA SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019) 154
  • FIGURE 55 MIDDLE EAST & AFRICA SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2020 & 2027) 154
  • FIGURE 56 MIDDLE EAST & AFRICA SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019 & 2027) 155
  • FIGURE 57 MIDDLE EAST & AFRICA SUBMENTAL FAT TREATMENT MARKET: BY TYPE (2020-2027) 155
  • FIGURE 58 GLOBAL SUBMENTAL FAT TREATMENT MARKET: COMPANY SHARE 2019 (%) 169
  • FIGURE 59 NORTH AMERICA SUBMENTAL FAT TREATMENT MARKET: COMPANY SHARE 2019 (%) 170
  • FIGURE 60 EUROPE SUBMENTAL FAT TREATMENT MARKET: COMPANY SHARE 2019 (%) 171
  • FIGURE 61 ASIA-PACIFIC SUBMENTAL FAT TREATMENT MARKET: COMPANY SHARE 2019 (%) 172